Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

68440 Press Releases
DateTitleCompany
18 May 12 Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2012 Salix Pharmaceuticals Ltd.,
Published by
Business Wire
18 May 12 Bruker Corporation to Host Inaugural Analyst Day Bruker Corporation,
Published by
Business Wire
18 May 12 Research and Markets: Tolcapone (CAS 134308-13-7) Market Research Report 2011 Research and Markets,
Published by
Business Wire
18 May 12 Forest and Almirall to Present Aclidinium Bromide Clinical Data at the American Thoracic Society (ATS) International Conference Forest Laboratories Inc.,
Published by
Business Wire
18 May 12 InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on Austin News Today Weekend and Detroit’s 7 Action News This Weekend InVivo Therapeutics Holdings Corp.,
Published by
Business Wire
18 May 12 NHS set to benefit from UK-led technologies Wellcome Trust and Department of Health
18 May 12 CSL Behring & HAE UK support HAE Day 2012 HAE UK
18 May 12 Shimadzu Corporation Introduces Ultra Fast Triple Quadrupole Gas Chromatograph Mass Spectrometer and Expands LC-MS/MS Portfolio Shimadzu Corporation,
Published by
Business Wire
18 May 12 Santarus Announces Presentation of UCERIS Phase III Extended Use Data at Digestive Disease Week Meeting Santarus Inc.,
Published by
Business Wire
18 May 12 Neurology Devices Market Investment Opportunities, Analysis and Forecasts to 2018 for Multiple Countries ReportsnReports,
Published by
PR Newswire
18 May 12 Dr. Reddy’s Announces the Launch of Clopidogrel Tablets, USP Dr. Reddy’s Laboratories,
Published by
Business Wire
18 May 12 New YouTube Channel Helps People Living with Inflammatory Bowel Disease Cornerstones Health Inc.,
Published by
Business Wire
18 May 12 Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses Emergent BioSolutions Inc.,
Published by
Business Wire
18 May 12 Lantheus Medical Imaging to Host First Quarter 2012 Conference Call on May 23, 2012 at 4:00 p.m. Eastern Time Lantheus Medical Imaging Inc.,
Published by
Business Wire
18 May 12 World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal Osiris Therapeutics Inc.,
Published by
Business Wire
18 May 12 Teva’s Board of Directors Votes to Re-Elect Dr. Phillip Frost as Chairman of the Board Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
18 May 12 Magellan Health Services to Present at Goldman Sachs 33rd Annual Global Healthcare Conference Magellan Health Services Inc.,
Published by
Business Wire
18 May 12 New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine Biogen Idec and Elan Corporation plc,
Published by
Business Wire
18 May 12 New Analysis of Risk Stratification for TYSABRI® Published in New England Journal of Medicine Elan Corporation plc,
Published by
Business Wire
18 May 12 Bio-Path Holdings Reports First Quarter 2012 Operational and Financial Results Bio-Path Holdings Inc.,
Published by
Business Wire
18 May 12 SQI Announces Closing of Second Tranche of Previously Announced Proposed Private Placement SQI Diagnostics Inc.,
Published by
Business Wire
18 May 12 Active Biotech and Ipsen to Present Tasquinimod Phase II Overall Survival Data at the 2012 ASCO Annual Meeting Ipsen,
Published by
Business Wire
17 May 12 RAPS Publishes New Book: Risk Evaluation and Mitigation Strategies for US Drug Development Regulatory Affairs Professionals Society (RAPS)
17 May 12 Dallas Jury Awards $10.66 Million in Lawsuit Alleging Breaches of Fiduciary Duties, Conversion, and Fraudulent Mismanagement of Medical Imaging Facilities ANDROVETT LEGAL MEDIA,
Published by
PR Newswire
17 May 12 Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer ESPERANCE PHARMACEUTICALS INC/MACDOUGALL BIOCOMMUNICATIONS,
Published by
PR Newswire
17 May 12 National Institutes Of Health Awards $350,000 To University Of Miami School Of Business For Cocaine Addiction Study UNIVERSITY OF MIAMI SCHOOL OF BUSINESS ADMINISTRATION,
Published by
PR Newswire
17 May 12 Elsevier / Gold Standard's Kay Morgan Awarded NCPCP Highest Honor Elsevier,
Published by
PR Newswire
17 May 12 NeuroMetrix CEO Discusses Significance of WellMed Adoption of NC-stat® DPNCheck™ NeuroMetrix,
Published by
Business Wire
17 May 12 Devon Medical Products Announces Strategic Alliance with PKUcare BeiYi Pharmaceutical Co. to Distribute U.S.-Made Medical Products in China Devon Medical Products,
Published by
Business Wire
17 May 12 Avraham Pharmaceuticals Announces Commencement of a Phase 2 Study of Ladostigil for the Treatment of MCI Avraham Pharmaceuticals Ltd.,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.